Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

March 10, 2026

Here's something that really caught my attention — Andrew Huberman, a Stanford neurobiology professor, says we’re on the brink of rewriting our biology. ((upbeat)) The pandemic sparked a health revolution, and now, with the rise of peptides and GLP drugs, we're seeing serious shifts in how people approach weight and focus. According to Huberman, these emerging neurotechnologies could soon let us tweak our brains and bodies at will. Daisy Wolf, hosting this chat, points out that science is catching up with what we once thought was sci-fi. So, what’s the big takeaway? Well, the tools to optimize focus, sleep, and even fight obesity are advancing fast, and the next five years could be revolutionary. ((thoughtful)) As content+a16zpodcast@a16z.com highlights, we’re moving toward a future where writing to our own biology might be just another part of everyday life. Honestly, this isn’t just speculation — it's happening, and it’s pretty fascinating to watch.

Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the neurotechnologies Huberman believes will let us write to our own biology within the next five years.

Resources:

Follow Andrew Huberman on X: https://twitter.com/hubermanlab

Follow Daisy Wolf on X: https://twitter.com/daisydwolf

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Audio Transcript